Understanding the interrelationships of clinical manifestations of Alzheimer’s disease (AD) and functional connectivity (FC) as the disease progresses is necessary for use of FC as a potential neuroimaging biomarker. Degradation of resting-state networks in AD has been observed when FC is estimated over the entire scan, however, the temporal dynamics of these networks are less studied. We implemented a novel approach to investigate the modular structure of static (sFC) and time-varying (tvFC) connectivity along the AD spectrum in a two-sample Discovery/Validation design (n = 80 and 81, respectively). Cortical FC networks were estimated across 4 diagnostic groups (cognitively normal, subjective cognitive decline, mild cognitive impairment, a...
Altered functional characteristics have been reported in amnestic mild cognitive impairment (aMCI) a...
Neurodegenerative brain changes can affect the functional connectivity strength between nodes of the...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer&#...
Understanding the interrelationships of clinical manifestations of Alzheimer’s disease (AD) and func...
Alzheimer's disease is considered a disconnection syndrome, motivating the use of brain network meas...
As findings on the neuropathological and behavioral components of Alzheimer’s disease (AD) continue ...
<div><p>Although anomalies in the topological architecture of whole-brain connectivity have been fou...
Alzheimer's disease (AD) is associated with abnormal resting-state network (RSN) architecture of the...
Altered functional characteristics have been reported in amnestic mild cognitive impairment (aMCI) a...
Although anomalies in the topological architecture of whole-brain connectivity have been found to be...
AbstractUnderstanding neural network dysfunction in neurodegenerative disease is imperative to effec...
<div><p>Altered functional characteristics have been reported in amnestic mild cognitive impairment ...
Understanding neural network dysfunction in neurodegenerative disease is imperative to effectively d...
Alzheimer's disease (AD) is a progressive disorder associated with cognitive dysfunction that alters...
Alzheimer's disease (AD) is a progressive disorder associated with cognitive dysfunction that alters...
Altered functional characteristics have been reported in amnestic mild cognitive impairment (aMCI) a...
Neurodegenerative brain changes can affect the functional connectivity strength between nodes of the...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer&#...
Understanding the interrelationships of clinical manifestations of Alzheimer’s disease (AD) and func...
Alzheimer's disease is considered a disconnection syndrome, motivating the use of brain network meas...
As findings on the neuropathological and behavioral components of Alzheimer’s disease (AD) continue ...
<div><p>Although anomalies in the topological architecture of whole-brain connectivity have been fou...
Alzheimer's disease (AD) is associated with abnormal resting-state network (RSN) architecture of the...
Altered functional characteristics have been reported in amnestic mild cognitive impairment (aMCI) a...
Although anomalies in the topological architecture of whole-brain connectivity have been found to be...
AbstractUnderstanding neural network dysfunction in neurodegenerative disease is imperative to effec...
<div><p>Altered functional characteristics have been reported in amnestic mild cognitive impairment ...
Understanding neural network dysfunction in neurodegenerative disease is imperative to effectively d...
Alzheimer's disease (AD) is a progressive disorder associated with cognitive dysfunction that alters...
Alzheimer's disease (AD) is a progressive disorder associated with cognitive dysfunction that alters...
Altered functional characteristics have been reported in amnestic mild cognitive impairment (aMCI) a...
Neurodegenerative brain changes can affect the functional connectivity strength between nodes of the...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer&#...